Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

SPIRA® Posterior Lumbar Spacers

K-Number: K230942 · 2023-07-11

Decision Date2023-07-11
Product CodeMAX
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

SPIRA® Posterior Lumbar Spacers is the device name listed in this FDA 510(k) record. The listed applicant is Camber Spine Technologies. It received FDA 510(k) clearance on 2023-07-11 under 510(k) number K230942. The device is classified under product code MAX. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the SPIRA® Posterior Lumbar Spacers?

SPIRA® Posterior Lumbar Spacers is a medical device that received FDA 510(k) clearance on 2023-07-11. The listed applicant is Camber Spine Technologies. The 510(k) number is K230942.

When did SPIRA® Posterior Lumbar Spacers receive FDA 510(k) clearance?

SPIRA® Posterior Lumbar Spacers received FDA 510(k) clearance on 2023-07-11, under 510(k) number K230942.

Who is the listed applicant for SPIRA® Posterior Lumbar Spacers?

The FDA 510(k) record lists Camber Spine Technologies as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for SPIRA® Posterior Lumbar Spacers?

The FDA product code for SPIRA® Posterior Lumbar Spacers is MAX.

Other records listing Camber Spine Technologies as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 22 devices →

Related Devices (Code: MAX)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.